Healthcare BPO Market Size At Around US$ 755.76 Bn In 2030

The healthcare BPO market would grow at a CAGR of 9.49% over the predicted time frame. The market is expected to increase in value from US$ 365.87 Bn in 2022 to US$ 755.76 Bn in 2030.

The on healthcare BPO Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2014

Report Scope of the Healthcare BPO Market

Report Coverage	Details
Market Size in 2022	USD 365.87 Billion
Market Size by 2030	USD 755.76 Billion
Growth Rate from 2022 to 2030	CAGR of 9.49%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Provider Service, Payer Service, Life Science Service, Geography

A recent report provides crucial insights along with application based and forecast information in the Global Healthcare BPO Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Healthcare BPO market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Healthcare BPO market are included as given below:

Healthcare BPO Market Key Players

• Accenture (Ireland)
• Access Healthcare (US)
• Akurate Management Solutions (US)
• Cognizant (US)
• Firstsource Solutions (India)
• GeBBS Healthcare Solutions (US)
• Genpact (US)
• HCL Technologies (India)
• IBM Corporation (US)
• Infosys BPM (India)
• Invensis Technologies (India)
• IQVIA (US)
• Lonza (Switzerland)
• Mphasis (India)
• NTT Data Corporation (Japan)
• Omega Healthcare (India)
• Parexel International (US)
• R1 RCM (US)
• Sutherland Global (US)
• Sykes Enterprises (US)
• Tata Consultancy Services (India)
• UnitedHealth Group (US)
• Wipro (India)
• WNS (Holdings) Limited (India)
• Xerox Corporation (US)

Market Segments

By Provider Service

• Revenue Cycle Management    
• Patient Enrolments         
• Patient Care      
  • Medical Transcription
  • Medical Imaging
  • Device Monitoring

By Payer Service

• Claims Management
  • Claims Adjudication Services
  • Claims Settlement Services
  • Information Management Services
  • Claims Repricing
  • Claims Investigation Services
  • Claims Indexing Services
  • Fraud Detection & Management
• Product Development & Business Acquisition (PDBA)              
• Member Management         
• Provider Management         
• Care Management 
• Integrated Front-End Services and Back-office Operations    
• Billing and accounts management services  
• HR Services

By Life Science Service

• Manufacturing
• R&D
• Non-Clinical Services             
  • Supply Chain Management & Logistics
  • Sales and Marketing Services
    • Forecasting
    • Performance Reporting
    • Analytics
    • Research
    • Marketing
  • Other Non-Clinical Services

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Philippines
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of the Middle East & Africa

Report Objectives

• To define, describe, and forecast the global healthcare BPO market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the healthcare BPO market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare BPO Market 

5.1. COVID-19 Landscape: Healthcare BPO Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare BPO Market, By Provider Service

8.1. Healthcare BPO Market, by Provider Service, 2022-2030

8.1.1 Revenue Cycle Management

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Patient Enrolments

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Patient Care

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare BPO Market, By Payer Service

9.1. Healthcare BPO Market, by Payer Service, 2022-2030

9.1.1. Claims Management

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Product Development & Business Acquisition (PDBA)

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Member Management

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Provider Management

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Care Management

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Integrated Front-End Services and Back-office Operations

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Billing and accounts management services 

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.8. HR Services

9.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare BPO Market, By Life Science Service 

10.1. Healthcare BPO Market, by Life Science Service, 2022-2030

10.1.1. Manufacturing

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. R&D

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Non-Clinical Services

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare BPO Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)

Chapter 12. Company Profiles

12.1. Accenture (Ireland)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Access Healthcare (US)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Akurate Management Solutions (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cognizant (US)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Firstsource Solutions (India)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GeBBS Healthcare Solutions (US)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genpact (US)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. HCL Technologies (India)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. IBM Corporation (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Infosys BPM (India)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com